AnnualReports.com – the leading provider of online annual reports to individual and institutional investors.

Savient Pharmaceuticals Inc.

Home » NASDAQ » Healthcare » Savient Pharmaceuticals Inc.

Savient Pharmaceuticals, Inc. operates as a specialty biopharmaceutical company in the United States. It engages in developing and commercializing KRYSTEXXA for the treatment of chronic gout in adult patients refractory to conventional therapy.

  • Annual Reports
View Online Reports: Order Free Hardcopy You can request a free hardcopy of this report mailed to you by clicking the button below.
Add Annual Report

No investor fact sheets added yet
No responsibility reports added yet

Browse Reports